Day: February 15, 2024

ATHENS, Greece, Feb. 15, 2024 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and twelve-month periods ended December 31, 2023.   Fourth Quarter 2023 Highlights:Total net revenues of $15.9 million.Net income attributable to controlling shareholders, of $0.3 million or $0.13 earnings per share basic and diluted.Adjusted net income1 attributable to controlling shareholders, for the quarter of $1.9 million, or, $0.71 and $0.70 per share basic and diluted, respectively.Adjusted EBITDA1 was $6.6 million.An average of 12.2 vessels were owned and operated during the fourth quarter of 2023 earning an average time charter equivalent rate of $14,570 per day.As...

First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept data in 2024 Highly selective oral SMARCA2 degrader PRT7732 IND expected to be filed in first half and enter Phase 1 clinical trial in second half of 2024 Recently established partnership with AbCellera to jointly discover, develop, and commercialize a portfolio of next generation precision ADCs Current cash runway into 2026 with $232.9 million in cash, cash equivalents and marketable securities as of December 31, 2023 WILMINGTON, Del., Feb. 15, 2024 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported its financial results for the fiscal year ended December 31, 2023, and outlined key objectives for 2024.    “In 2023, we...

Increases Quarterly Dividend 11% to $0.61 per Share LOUISVILLE, Ky., Feb. 15, 2024 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 and 52 weeks ended December 26, 2023. Financial Results Financial results for the 13 and 52 weeks ended December 26, 2023 and December 27, 2022 were as follows:                                         13 Weeks Ended   52 Weeks Ended    ($000’s)   December 26,2023   December 27,2022   % change   December 26,2023   December 27,2022   % change    Total revenue   $ 1,164,361   $ 1,009,529   15.3 % $ 4,631,672   $ 4,014,919   15.4 %  Income from operations     83,773     68,853   21.7 %   353,989     320,197   10.6 %  Net income     72,430     59,869   21.0 %   304,876     269,818   13.0 %  Diluted earnings per share   $ 1.08   $ 0.89   21.3 % $ 4.54   $ 3.97   14.3 %  Results...

SANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2023. Recent HighlightsRecognized revenue of $203.0 million for the fourth quarter of 2023 and $730.2 million for the full year 2023, representing increases of 41% and 49%, respectively, from the same periods in 2022 Initiated the full U.S. commercial launch of the Shockwave C2+ Coronary Intravascular Lithotripsy (IVL) catheter Granted new physician and hospital reimbursement for coronary IVL in the United States. Three newly created MS-DRGs specific to coronary IVL for hospital payment in the inpatient setting became effective...

Arthur Mueller Retires from Board of Directors; Board Appoints Greg Mueller as Director   OTTAWA, Ill., Feb. 15, 2024 (GLOBE NEWSWIRE) — Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for OSB Community Bank (the “Bank”), announced net income of $0.2 million, or $0.08 per basic and diluted common share for the three months ended December 31, 2023, compared to net income of $0.5 million, or $0.22 per basic and diluted common share for the three months ended December 31, 2022. For the year ended December 31, 2023, the Company announced net income of $1.7 million, or $0.66 per basic and diluted common share, compared to net income of $2.5 million, or $0.96 per basic and diluted common share for the year ended December 31, 2022. The loan portfolio, net of allowance, increased to $312.2 million as of December...

HUNTINGTON BEACH, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) today reported financial results for its fiscal 2023 fourth quarter and year ended Tuesday, January 2, 2024. Fiscal Fourth Quarter 2023 Compared to Fourth Quarter 2022Total revenues decreased 6.0% to $323.6 million (13 weeks vs. 14 weeks)Excluding the extra operating week in fiscal 2022, fourth quarter 2023 revenues increased 0.9% compared to the same quarter in the prior yearComparable restaurant sales increased 0.6% (13 weeks vs. 13 weeks) Total restaurant operating weeks decreased 6.1% (13 weeks vs. 14 weeks) Net income of $8.1 million, compared to $4.0 million; diluted net income per share of $0.34, compared to $0.17 (13 weeks vs. 14 weeks) Adjusted EBITDA of $27.3 million, compared to $26.1 million, as described below in...

Revenue $6.71 billion, flat year over year GAAP operating margin 29.3 percent and non-GAAP operating margin 29.5 percent, up 0.1 points and flat year over year, respectively GAAP EPS $2.41 and non-GAAP EPS $2.13, up 19 percent and 5 percent year over year, respectively Generated $2.33 billion in cash from operationsSANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — Applied Materials, Inc. (NASDAQ: AMAT) today reported results for its first quarter ended Jan. 28, 2024. First Quarter Results Applied generated revenue of $6.71 billion. On a GAAP basis, the company reported gross margin of 47.8 percent, operating income of $1.97 billion or 29.3 percent of net revenue, and earnings per share (EPS) of $2.41. On a non-GAAP basis, the company reported gross margin of 47.9 percent, operating income of $1.98 billion or 29.5 percent...